Alcon (ALC) | Financial Analysis & Statements

Alcon Inc. | Large-cap | Healthcare

$87.78

-1.70%

Alcon vs Intuitive Surgical Alcon vs Becton, Dickinson Alcon vs ResMed Alcon vs West Pharmaceutical Alcon vs Baxter International Alcon vs S&P 500 | Market

Overview Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

Financial Overview

Latest Annual: 2024

Income Metrics

Revenue 9.9B

Gross Profit 5.5B 55.61%

Operating Income 1.4B 14.26%

Net Income 1.0B 10.27%

EPS (Diluted) $2.05

Balance Sheet Metrics

Total Assets 30.3B

Total Liabilities 8.8B

Shareholders Equity 21.6B

Debt to Equity 0.41

Cash Flow Metrics

Operating Cash Flow 2.5B

Free Cash Flow 1.4B

Revenue & Profitability Trend

Alcon Income Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Revenue	9.9B	9.5B	8.7B	8.3B	6.8B
Cost of Goods Sold	4.4B	4.2B	4.0B	3.6B	3.9B
Gross Profit	5.5B	5.2B	4.7B	4.7B	2.9B
Operating Expenses	4.1B	4.2B	4.1B	4.1B	3.4B
Operating Income	1.4B	1.0B	672.0M	580.0M	-482.0M
Pre-tax Income	1.3B	832.0M	463.0M	418.0M	-635.0M
Income Tax	238.0M	-142.0M	128.0M	42.0M	-104.0M
Net Income	1.0B	974.0M	335.0M	376.0M	-531.0M
EPS (Diluted)	$2.05	$1.96	$0.68	$0.76	-$1.09

Income Statement Trend

Alcon Balance Sheet From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Assets
Current Assets	6.3B	5.6B	5.2B	5.4B	5.0B
Non-Current Assets	24.0B	24.0B	24.0B	22.6B	22.6B
Total Assets	30.3B	29.6B	29.2B	28.0B	27.6B
Liabilities
Current Liabilities	2.3B	2.5B	2.7B	2.5B	2.3B
Non-Current Liabilities	6.5B	6.5B	6.8B	6.3B	6.5B
Total Liabilities	8.8B	9.0B	9.5B	8.7B	8.8B
Equity
Total Shareholders Equity	21.6B	20.6B	19.7B	19.3B	18.8B

Balance Sheet Composition

Alcon Cash Flow Statement From 2020 to 2024

Metric	2024	2023	2022	2021	2020
Operating Activities
Net Income	1.0B	974.0M	335.0M	376.0M	-531.0M
Operating Cash Flow	2.5B	1.7B	1.3B	1.6B	1.1B
Investing Activities
Capital Expenditures	-473.0M	-658.0M	-636.0M	-700.0M	-473.0M
Investing Cash Flow	-970.0M	-901.0M	-1.8B	-718.0M	-484.0M
Financing Activities
Dividends Paid	-130.0M	-116.0M	-100.0M	-54.0M	0
Financing Cash Flow	-322.0M	-245.0M	-50.0M	-166.0M	466.0M
Free Cash Flow	1.4B	537.0M	472.0M	165.0M	256.0M

Cash Flow Trend

Alcon Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 38.45

Forward P/E 24.58

Price to Book 1.95

Price to Sales 4.31

PEG Ratio 24.58

Profitability Ratios

Profit Margin 11.28%

Operating Margin 13.30%

Return on Equity 5.23%

Return on Assets 2.74%

Financial Health

Current Ratio 2.70

Debt to Equity 23.63

Beta 0.75

Per Share Data

EPS (TTM) $2.25

Book Value per Share $44.39

Revenue per Share $20.06

Peer Financial Comparison

Company	Market Cap	P/E Ratio	P/B Ratio	ROE	Profit Margin	Debt/Equity
alc	42.8B	38.45	1.95	5.23%	11.28%	23.63
Intuitive Surgical	184.6B	75.42	10.79	15.96%	28.41%	0.00
Becton, Dickinson	48.6B	32.89	1.93	5.89%	7.18%	76.34
ResMed	37.3B	28.60	6.73	25.81%	26.15%	15.14
West Pharmaceutical	16.0B	34.96	5.96	17.42%	16.13%	11.46
Baxter International	15.4B	133.76	2.17	-3.51%	-5.20%	146.14

Financial data is updated regularly. All figures are in the company's reporting currency.